Can Near-Infrared Light Stimulate the Vagus Nerve?

Near-infrared light aimed below the ear may sound like a convenient route to vagus-nerve stimulation: no electrodes, no needles, no complicated setup. A 2026 trial found one statistically significant change in heart-rate variability after this approach. But the result was a reduction in approximate entropy (ApEn; p=0.011), while the other major HRV measures did not change. That makes this an interesting lead, not evidence that an ear-targeted light device can improve vagal tone.

The study tested photobiomodulation (PBM), a form of light therapy more commonly studied for muscle and soft-tissue recovery, at the infra-auricular area near the auricular branch of the vagus nerve. The anatomical idea has a real starting point: electrical stimulation at parts of the ear can affect cardiac autonomic measures through vagal pathways. The leap from electrical stimulation to photons, however, remains unproven.

What the light-therapy trial found

In the 2026 Pereira et al. trial, 34 physically active adults took part in an acute randomized controlled study. The exercise comparison tested 850 nm PBM, delivering 12 J to the infra-auricular region, combined with resistance exercise versus exercise alone. The publication also included a group of 17 participants who received PBM without exercise. Researchers assessed HRV using time-domain, frequency-domain, and nonlinear measures.

Only ApEn differed significantly in the PBM-plus-exercise comparison: it fell modestly, with p=0.011. RMSSD, SDNN, high-frequency power, and the LF/HF ratio did not show significant differences. The authors described the result as minimal acute modulation and called for studies using different dosimetry.

ApEn describes the moment-to-moment regularity or complexity of a heart-rate signal. It is an HRV metric, not a clinical outcome. The trial did not show that light improved cardiovascular health, recovery, stress resilience, arrhythmia risk, or longevity. It measured an immediate biomarker after a single intervention session.

Why one positive HRV metric is hard to interpret

The study examined several HRV measures across several analytical domains but did not report a correction for multiple comparisons. When researchers run many statistical tests, one apparently positive result can occur by chance even if the intervention has no effect. A p-value of 0.011 is below the conventional 0.05 threshold for that individual comparison, but it does not settle the question when it appears alone in a larger testing battery.

The outcome also sits in a measurement category that needs careful handling. Uryga et al. in 2025 reported that HRV and pulse-rate-variability metrics, including nonlinear measures, can change substantially with signal length and analysis-window choices. Post-exercise recordings add another challenge: breathing and heart rhythm are recovering toward baseline rather than holding steady. Those conditions can make entropy measures especially sensitive to recording and processing decisions.

Unblinded treatment assignment creates another plausible route to a false signal. Participants who know they received an active intervention may breathe, pace their recovery, or change their behavior differently. Breathing strongly affects HRV. The trial design therefore cannot separate a small ApEn difference caused by breathing or recovery behavior from one caused by vagal photostimulation.

What genuine autonomic modulation usually looks like

A single HRV number rarely gives a complete account of autonomic activity. In a study of 70 healthy people exposed to controlled breathing, Uryga et al. in 2024 found concurrent changes across linear and nonlinear autonomic measures. Research on autonomic dysregulation during periodic limb movements has likewise reported coordinated differences across linear and nonlinear HRV domains, as described by Issi et al.

These studies do not establish a rule that every valid vagal intervention must move every HRV metric in the same direction. HRV is biologically and mathematically complicated. They do show why isolated entropy findings deserve caution, especially when RMSSD and high-frequency power—the measures commonly used as markers of parasympathetic cardiac activity—do not corroborate the result.

Electrical ear stimulation has a clearer mechanism

Transcutaneous auricular vagus nerve stimulation, or taVNS, uses electrical current at ear locations supplied by the auricular branch of the vagus nerve. The proposed pathway runs from that branch to the nucleus tractus solitarii and then to brainstem circuits involved in cardiac parasympathetic outflow. In healthy young participants, Forte et al. found that electrical auricular stimulation could modulate HRV.

That evidence supports the ear as a plausible autonomic target. It does not prove that any stimulus applied near the ear reaches the same pathway. Electrical taVNS directly applies current intended to excite neural tissue. PBM would need 850 nm photons delivered at the skin surface to reach an anatomically relevant nerve target and trigger a meaningful photochemical response. Published evidence has not established photon penetration to the auricular branch at this infra-auricular site, nor a dose-response threshold for neural photoactivation there.

Even electrical taVNS is not plug-and-play. In a randomized crossover trial, Atanackov et al. in 2025 found that acute HRV effects varied with stimulation frequency and pulse width. Maestri et al. in 2024 also found that optimized electrical stimulation required specific parameter choices to alter cardiac autonomic profiles in healthy participants and people with heart failure. Baseline parasympathetic activity can further influence responsiveness, according to Schiweck et al.

Those findings matter for the PBM study because its 12 J dose has no validated neural dosimetry behind it. Physically active adults may also begin with relatively high parasympathetic tone, leaving less room for an acute increase. The trial did not stratify participants by baseline HRV, so it could not distinguish low responsiveness from a true absence of effect.

Non-electrical stimulation is possible, but the route matters

Non-electrical ear interventions should not be dismissed automatically. A randomized trial by Trinh et al. in 2025 reported enhanced vagal tone and HRV modulation with auricular acupressure at Point Zero. Mechanical pressure has a more direct physical route to superficial mechanoreceptors and nerve endings than light has to a deeper nerve target. That distinction does not validate acupressure for every use, but it makes acupressure poor evidence for PBM by analogy.

Similarly, Széles et al. reported HRV changes with bursted percutaneous auricular vagus nerve stimulation in healthy people. Percutaneous electrical stimulation and surface light irradiation are fundamentally different exposures. The fact that one can alter HRV does not tell us whether the other can activate the same nerve.

What would make the next study persuasive

A useful follow-up would begin with anatomy and optics: demonstrate that the chosen wavelength and dose reach the relevant nerve tissue at the infra-auricular site. It would then use a credible sham, pre-register one or a small number of primary HRV outcomes, correct for multiple testing, standardize breathing and exercise recovery, and enroll enough participants to deal with the variability of entropy metrics. Direct evidence of neural engagement would help far more than another isolated HRV result.

Researchers would also need to show whether any effect lasts beyond a single session and whether it changes outcomes people actually care about. An acute shift in a surrogate measure can be biologically interesting without being clinically useful.

Verdict: evidence grade D for PBM as auricular vagal stimulation. The 2026 trial raises a legitimate question, but its lone ApEn result cannot support a post-workout PBM protocol, a claim that ear light devices improve HRV, or a recommendation for 850 nm at 12 J. Electrical taVNS has a more developed evidence base and a defined neural mechanism. Infra-auricular PBM remains a hypothesis waiting for a better test.